Q702
Near Add Your Location
Not yet accepting
Q702
MC220806: Phase I Study Evaluating the Efficacy of CSF1R and TAM Receptor or Inhibition in Hematologic Malignancies With Q702, a Small Molecular Inhibitor
- AXL Inhibitor
- CSF1R Inhibitor
- Phase 1
Not yet accepting